Australia’s Atomo Seeks to Produce Rapid Coronavirus Self-Tests

Mar.24 — John Kelly, founder and chief executive officer of Atomo Diagnostics, an Australian rapid blood test maker backed by the Bill & Melinda Gates Foundation’s Global Health Investment Fund, talks about the company’s plan to list shares in April and use the funds to manufacture millions of rapid self-tests for coronavirus. Kelly speaks on “Bloomberg Markets.”

Leave a Comment